NASDAQ:CITE Cartica Acquisition (CITE) Stock Price, News & Analysis → Jeff Bezos Just Humiliated Elon Musk (From InvestorPlace) (Ad) Free CITE Stock Alerts $11.14 0.00 (0.00%) (As of 05/6/2024 ET) Add Compare Share Share Today's Range$11.14▼$11.1450-Day Range$10.90▼$11.2052-Week Range$10.34▼$12.67Volume60 shsAverage Volume38,459 shsMarket Capitalization$110.95 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Get Cartica Acquisition alerts: Email Address Ad Behind the MarketsRevealed: The Unknown Biotech Powering AI in HealthcareThe CEO of Google predicted this is "one of the most important things for humanity." We're standing at the brink of an AI revolution in medicine, a leap forward that will change the future medicine as we know it. If you're only watching tech giants like NVIDIA and Google for AI investments, you're missing the biggest opportunities... Because I've uncovered a little known biotech at the heart of this AI medical revolution.To discover the name and ticker of this hidden gem click here>>>> About Cartica Acquisition Stock (NASDAQ:CITE)Cartica Acquisition Corp does not have any significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify and complete a business combination in the technology sector in India. Cartica Acquisition Corp was incorporated in 2021 and is based in Washington, the District of Columbia.Read More CITE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CITE Stock News HeadlinesMay 2, 2024 | americanbankingnews.comCartica Acquisition Corp (NASDAQ:CITE) Short Interest UpdateFebruary 6, 2024 | finance.yahoo.comOwning 48% shares,institutional owners seem interested in Cartica Acquisition Corp (NASDAQ:CITE),See More Headlines Receive CITE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cartica Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorUnclassified Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:CITE CUSIPN/A CIK1848437 Webcarticaspac.com Phone202-367-3003FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares9,960,000Free Float4,514,000Market Cap$110.95 million OptionableNot Optionable Beta0.02 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Suresh Guduru (Age 50)CEO & Chairman Mr. Chad Brian Coad C.F.A. (Age 54)COO & CFO Mr. Suresh Singamsetty (Age 49)Chief Investment Officer & Director Key CompetitorsTarget Global Acquisition INASDAQ:TGAAPerception Capital Corp. IIINASDAQ:PFTACapitalworks Emerging Markets AcquisitionNASDAQ:CMCACF Acquisition Corp. VIINASDAQ:CFFSCompass Digital AcquisitionNASDAQ:CDAQView All CompetitorsInstitutional OwnershipBerkley W R CorpBought 141,110 shares on 2/15/2024Ownership: 4.412%Glazer Capital LLCBought 245,507 shares on 2/15/2024Ownership: 4.224%Mizuho Securities USA LLCBought 170,187 shares on 2/8/2024Ownership: 1.709%Cowen AND Company LLCSold 55,145 shares on 2/8/2024Ownership: 1.506%Robinson Capital Management LLCSold 4,664 shares on 2/8/2024Ownership: 0.409%View All Institutional Transactions CITE Stock Analysis - Frequently Asked Questions How have CITE shares performed in 2024? Cartica Acquisition's stock was trading at $10.91 at the start of the year. Since then, CITE stock has increased by 2.1% and is now trading at $11.14. View the best growth stocks for 2024 here. Are investors shorting Cartica Acquisition? Cartica Acquisition saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 3,400 shares, an increase of 6.3% from the March 31st total of 3,200 shares. Based on an average daily trading volume, of 23,300 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.1% of the company's shares are short sold. View Cartica Acquisition's Short Interest. How do I buy shares of Cartica Acquisition? Shares of CITE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CITE) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersNo experience to confident trader, meet my student…Wealth Builders InstituteBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm PressRevealed: The Unknown Biotech Powering AI in HealthcareBehind the MarketsOil Surge Predicted... But Are You ReadyThe Oxford ClubMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceWarren Buffet Stockpiling Gold?Reagan Gold GroupControversial CEO explains new way to amass wealthStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cartica Acquisition Corp Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.